Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nexalin Technology (NXL) EBT (2021 - 2025)

Nexalin Technology (NXL) has 5 years of EBT data on record, last reported at -$2.3 million in Q3 2025.

  • For Q3 2025, EBT rose 7.03% year-over-year to -$2.3 million; the TTM value through Sep 2025 reached -$8.7 million, down 56.1%, while the annual FY2024 figure was -$7.6 million, 63.75% down from the prior year.
  • EBT reached -$2.3 million in Q3 2025 per NXL's latest filing, down from -$1.6 million in the prior quarter.
  • Across five years, EBT topped out at -$293194.0 in Q3 2022 and bottomed at -$2.8 million in Q4 2024.
  • Average EBT over 5 years is -$1.3 million, with a median of -$1.0 million recorded in 2024.
  • Peak YoY movement for EBT: surged 83.91% in 2022, then tumbled 683.5% in 2023.
  • A 5-year view of EBT shows it stood at -$577489.0 in 2021, then decreased by 26.95% to -$733113.0 in 2022, then dropped by 6.49% to -$780669.0 in 2023, then crashed by 262.95% to -$2.8 million in 2024, then grew by 19.66% to -$2.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were -$2.3 million in Q3 2025, -$1.6 million in Q2 2025, and -$2.0 million in Q1 2025.